Welcome to LookChem.com Sign In|Join Free

Hubei Vanz Pharm Co.,Ltd

Diamond Supplier Enterprise Certification

Diamond
Supplier
5th
years
Home>>Products>>Cosmetics Raw Material Acitretin USP Grade Acitretin CAS 55079-83-9 Skin Disease

Product Certification&
Enterprise Certification

More Detail

Hubei Vanz Pharm Co.,Ltd

Country: China (Mainland)

Business Type:Trading Company

Ms.Chelsea gao

Tel: 86-27-84492310

Ms.Bella Li

Tel: 008618986076206

Ms.Chelsea Gao

Tel: +86 27 84492310

Ms.Wendy

Tel: WhatsApp +8615927784577

Ms.Mirriam

Tel: +8618071739296

Mobile:

Tel: 86-27-84492310

Fax: 86-27-84402310

URL: http://www.vanzpharm.com/en/index.html

Province/state: Hubei

City: JIAYU

Street: FANHU INDUSTRY PARK

MaxCard:


    x
  • Ms.Bella Li
  • Ms.Chelsea Gao
Contact Suppliers

Cosmetics Raw Material Acitretin USP Grade Acitretin CAS 55079-83-9 Skin Disease

CAS NO.55079-83-9

  • Min.Order: 1 Kilogram
  • Payment Terms: L/C,T/T,MoneyGram
Contact Supplier

Product Details

Keywords

  • Acitretin
  • Acitretin powder
  • 99% Acitretin

Quick Details

  • ProName: Cosmetics Raw Material Acitretin USP G...
  • CasNo: 55079-83-9
  • Molecular Formula: C15H22O5
  • Appearance: white
  • Application: Acitretin
  • DeliveryTime: 7-10 days
  • PackAge: drum
  • Port: Shanghai/Wuhan
  • ProductionCapacity: 1000 Kilogram/Month
  • Purity: 99
  • Storage: room
  • LimitNum: 1 Kilogram

Superiority

Cosmetics Raw Material Acitretin USP Grade Acitretin CAS 55079-83-9 Skin Disease

product :Acitretin
CAS:55079-83-9
MF:C21H26O3
MW:326.43
EINECS:259-474-4
Melting point:228-230°C

Details

Cosmetics Raw Material Acitretin USP Grade Acitretin CAS 55079-83-9 Skin Disease 

product :Acitretin
CAS:55079-83-9
MF:C21H26O3
MW:326.43
EINECS:259-474-4
Melting point:228-230°C

What is  Acitretin   

Acitretin is the free acid form of etretinate useful in the treatment of severe psoriasis and other disorders of keratinization. Although the two compounds have virtually the same efficacy and teratogenic side-effects, acitretin is advantageous for child-bearing women, as its shorter half-life reduces the necessary contraception period from two years to only one month after treatment ceases.